Peter M Kash's Net Worth

$6.48 Million

Estimate Recalculated Sep 9, 2024 12:20AM EST

Who is Peter M Kash

Peter M Kash has an estimated net worth of $6.48 Million. This is based on reported shares across multiple companies, which include DENALI SCIENCES, INC., Arno Therapeutics, Inc, INTRAC INC, Nile Therapeutics, Inc., and KERYX BIOPHARMACEUTICALS INC.

SEC CIK

Peter M Kash's CIK is 0001253023

Past Insider Trading and Trends

2006 was Peter M Kash's most active year for acquiring shares with 9 total transactions. Peter M Kash's most active month to acquire stocks was the month of November. 2004 was Peter M Kash's most active year for disposing of shares, totalling 1 transactions. Peter M Kash's most active month to dispose stocks was the month of December. 2006 saw Peter M Kash paying a total of $983,522.57 for 332,935 shares, this is the most they've acquired in one year. In 2006 Peter M Kash cashed out on 26,575 shares for a total of $107,628.75, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DENALI SCIENCES, INC.

Investor
Updated May 29, 2007
Form 4
25.00K
May 29, 2007
353.34K
Grant
May 24
Form 3
Mar 07, 2007
328.34K
Showing 2 results

Arno Therapeutics, Inc

Investor
Updated Jun 13, 2008
Form 3
Jun 13, 2008
1.81M
Showing 1 results

INTRAC INC

Investor
Updated Dec 12, 2006
Form 4
25.73%
226.26K
$3.82
$857.35K
Dec 12, 2006
1.11M
Acquisition
Dec 08
Form 4
1.28%
5.00K
$3.65
$18.24K
Dec 01, 2006
469.43K
Purchase
Nov 29
Form 4
0.03%
100.00
$3.00
$300.00
Jun 14, 2006
391.57K
Purchase
Jun 09
Form 4
36.69%
75.00K
May 01, 2006
279.41K
Grant
Mar 08
Form 4
28.29%
245.00K
$3.20
$32.00K
Nov 30, 2005
1.11M
Purchase
Nov 07 - Nov 22
Form 4
7.35%
55.00K
Apr 13, 2005
803.69K
Grant
Apr 12
Form 3
Jan 11, 2005
454.33K
Showing 7 results

Nile Therapeutics, Inc.

Investor
Updated Jul 19, 2011
Form 4
19.50K
Jul 19, 2011
2.84M
Acq/Dis
Jul 18
Form 4
80.00K
May 12, 2011
2.82M
Grant
May 10
Form 4
80.00K
Jul 28, 2010
2.74M
Grant
Jul 26
Form 4
80.00K
Jul 23, 2009
2.66M
Grant
Jul 21
Form 4
125.00K
Jul 16, 2009
2.58M
Acq/Dis
Jul 15
Form 4
13.20%
197.63K
Jul 09, 2009
2.45M
Purchase
Jul 07
Form 4
35.00K
Dec 23, 2008
35.00K
Grant
Dec 23
Form 4
0.31%
4.60K
$1.19
$5.48K
Dec 12, 2008
2.16M
Purchase
Dec 11 - Dec 12
Form 4
60.00K
Jan 29, 2008
60.00K
Grant
Jan 25
Showing 9 results

KERYX BIOPHARMACEUTICALS INC

Investor
Updated Feb 02, 2004
Form 4
-13.62%
-120.00K
$0.10
-$12.00K
Feb 02, 2004
760.75K
Sale
Jan 29
Showing 1 results